Related Experiment Video

Updated: May 26, 2025

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.5K

Editorial: The mechanistic investigation and emerging therapies for Friedreich's ataxia

Yina Dong1,2, Vijayendran Chandran3, Elisabetta Soragni4

  • 1Department of Pediatrics and Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.

Frontiers in Pharmacology
|February 25, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Friedreich’s Ataxiaantioxidant therapyfrataxin regulationgene - editingmitochondrial dysfunctionoxidative stress

More Related Videos

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.6K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.5K

Related Experiment Videos

Last Updated: May 26, 2025

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.5K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.6K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.5K

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

13.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.8K

Articles linked to this work by shared authors, journal, and citation graph.

The Cardiac Calcium Handling Machinery is Remodeled in Friedreich's Ataxia.

Heart rhythm·2026

Friedreich Ataxia: From Genetics to Mechanism to Clinical Features.

Annual review of pathology·2026

Serial assessment of echocardiographic measures in Friedreich ataxia.

American heart journal plus : cardiology research and practice·2026

Impaired Glur2 palmitoylation in cerebellar Purkinje cells of a Friedreich ataxia mouse model.

Experimental neurology·2026

Stem Cell Transplantation in Friedreich Ataxia: Cure for Leukemia but No Effect on Neurological Progression.

Annals of clinical and translational neurology·2026

Advances in Gene and Cellular Therapy in Friedreich Ataxia.

Molecular diagnosis & therapy·2026

A review of protective effects of Withania somnifera and its bioactive component withaferin A in organ ischemia-reperfusion injury.

Frontiers in pharmacology·2026

Thioredoxin system: mechanisms and therapeutic potential in mental disorders.

Frontiers in pharmacology·2026

Targeting the secretory autophagy-extracellular vesicle interface: fate decisions and translational opportunities.

Frontiers in pharmacology·2026

AI-driven multi-omics biomarkers in precision breast cancer therapeutics: from discovery to clinical translation.

Frontiers in pharmacology·2026

Pimpinella brachycarpa extract attenuates periodontal inflammation by modulating the PI3K/Akt-NF-κB signaling pathway.

Frontiers in pharmacology·2026

From respiratory viral infection to persistent cough hypersensitivity: neuroimmune regulation and therapeutic implications of P2X3/TRP ion-channel targets.

Frontiers in pharmacology·2026

A compartment-resolved framework for microbial sulfur-reactive sulfur signaling in diabetic cardiomyopathy: from gut metabolism to cardiac sulfur responses.

Frontiers in microbiology·2026

Neurobiological mechanisms and brain network dysfunction in major depressive disorder: an integrative review.

Frontiers in integrative neuroscience·2026

Clinical spectrum and genotype-phenotype correlations of MT-CYB-associated mitochondrial disease: from the m.15045G > A variant to the broader disease landscape.

Frontiers in neuroscience·2026

Nucleotide Metabolic Reprogramming in Sepsis: From Immune-Cell Fate to Organ Injury and Precision Therapeutics.

Journal of inflammation research·2026

Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis.

Frontiers in pharmacology·2026

Transcriptome profiling of Saccharomyces cerevisiae under 3-bromopyruvate treatment.

Journal of applied genetics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us